GEODE CAPITAL MANAGEMENT, LLC - BENITEC BIOPHARMA INC ownership

BENITEC BIOPHARMA INC's ticker is BNTC and the CUSIP is 08205P100. A total of 16 filers reported holding BENITEC BIOPHARMA INC in Q1 2021. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
GEODE CAPITAL MANAGEMENT, LLC ownership history of BENITEC BIOPHARMA INC
ValueSharesWeighting
Q2 2023$11,501
+13.6%
48,2230.0%0.00%
Q1 2023$10,122
+126425.0%
48,223
-2.5%
0.00%
Q4 2022$8
-100.0%
49,469
-18.9%
0.00%
Q3 2022$22,000
-68.6%
60,967
+0.8%
0.00%
Q2 2022$70,000
-49.6%
60,481
+1.5%
0.00%
Q1 2022$139,000
-9.2%
59,566
+2.0%
0.00%
Q4 2021$153,000
-19.9%
58,413
+8.8%
0.00%
Q3 2021$191,000
+30.8%
53,692
+55.7%
0.00%
Q2 2021$146,000
-0.7%
34,493
+20.8%
0.00%
Q1 2021$147,00028,5600.00%
Other shareholders
BENITEC BIOPHARMA INC shareholders Q1 2021
NameSharesValueWeighting ↓
SUVRETTA CAPITAL MANAGEMENT, LLC 769,000$1,796,0000.06%
Atom Investors LP 37,335$87,0000.04%
SILVERARC CAPITAL MANAGEMENT, LLC 492,880$57,0000.02%
WealthTrust Axiom LLC 12,950$30,0000.01%
UBS Group AG 347$1,0000.00%
WELLS FARGO & COMPANY/MN 43$00.00%
NORTHERN TRUST CORP 11,813$28,0000.00%
CONCOURSE FINANCIAL GROUP SECURITIES, INC. 0$00.00%
GROUP ONE TRADING, L.P. 2,000$5,0000.00%
GEODE CAPITAL MANAGEMENT, LLC 59,566$139,0000.00%
View complete list of BENITEC BIOPHARMA INC shareholders